PER 1.18% 8.6¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-9

  1. 35,692 Posts.
    lightbulb Created with Sketch. 552

    Alzheimers would be a stupid target for ANP !

    A lot of money, a lot of time, large trials and a biotech graveyard with 99% failure rate - leave that stuff to big pharma with money to burn.

    ANP’s best to stick with rare diseases which i think they will - as is we still need to finding the funding for the IIB trial.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.6¢
Change
0.001(1.18%)
Mkt cap ! $77.53M
Open High Low Value Volume
8.5¢ 8.8¢ 8.4¢ $18.63K 218.7K

Buyers (Bids)

No. Vol. Price($)
1 30000 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 46681 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.